BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, May 1, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 6, 2001
View Archived Issues
Indatraline/buprenorphine therapy reduces speedball use in monkeys
Read More
Preliminary results reported for pilot study of Titan's Spheramine in advanced Parkinson's disease
Read More
MBI-594AN phase II clinical trial for acne completes enrollment
Read More
Arrhythmogenicity of nesiritide and dobutamine compared in CHF patients
Read More
New tablet form of Rapamune for kidney transplants now available in the U.S.
Read More
Enrollment begins for phase II trial of Metastat in HIV-related Kaposi's sarcoma
Read More
FDA accepts resubmission to the BLA for Zevalin
Read More
PPI rabeprazole and thioester derivative inhibit motility and growth of CRHP
Read More
IND application submitted for Product R
Read More
Phase I trial of Triapine in combination with gemcitabine set to begin
Read More
ZD-6021, AstraZeneca's tachykinin receptor antagonist, characterized
Read More
Interaction between parkin and alpha-synuclein in Parkinson's disease revealed
Read More
Low vitamin B12 and folate levels may increase risk of AD
Read More
Oral paclitaxel shows promising results in phase II lung cancer trials
Read More
Phase I/II trials evaluating PI-88 for cancer set to begin
Read More
C&C Research reports compounds useful as antiestrogenic agents
Read More
Pfizer patents novel protein kinase inhibitors
Read More
Muscarinic antagonists and agonists reported by Advanced Medicine
Read More
Phase II trial planned for Aphton's antigastrin-targeted therapy in lung cancer patients
Read More
Mitsubishi-Tokyo Pharmaceuticals describes new Alzheimer's disease compounds
Read More
